skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I am trying to understand Pfizer. In September it was trading at $36 and change. Today after all the good news about the vaccine it is at $39 and change. This seems like a small increase given the good it is doing and news, etc. However, if there were reports of a few bad reactions (or worse, sorry to say), the stock would tank. Can you help me understand this or maybe I am seeing it all wrong. Thanks again.
Read Answer Asked by Danny-boy on December 15, 2020
Q: Can you please rate these companies according to growth opportunities and another rating for risk? Thanks!
Read Answer Asked by Sandy on December 15, 2020
Q: Could I have your thoughts on BioHaven. It has a new drug for acute treatment of migraine headaches and seems to be very effective. Their stock has progressed since the drug was first put on the market earlier this year. How do they look financially? I believe they have an interest in another company Kleo Pharmaceuticals. I believe The Bill & Melinda Gates Foundation has also given Kleo a substantial grant.
Thanks John
Read Answer Asked by John on December 15, 2020
Q: Hello Peter, assuming an already have a diversified portfolio, in what order would you choose the following for long-term wealth creation (whether from dividends or gains): ETSY, PINS, SQ, NVDA, LSPD, ADBE, ARKW, MKP. Thank you.
Read Answer Asked by James on December 15, 2020
Q: 2 recent purchases of mine SNOW which is falling faster than the snow outside, and NXPI I am under water since the day after I bought it (3 days ago), now Goldman Sacks has downgraded the stock - your opinion and SNOW was also falling on after hours trading below what it closed at 4 o'clock - appreciate your input on these 2 cases. Thanks,
Read Answer Asked by Dennis on December 15, 2020
Q: Hi Peter, I'm just wondering about any new views since the 3rd of Sept comment. Would this also be a good play on the vaccine investments for 2021. Each person needs 2 doses - that's a lot of syringes and needles! Would Becton benefit or is there too many competition suppliers out there (market share?) and/or doesn't make too much towards its total annual profits? Thanks.
Read Answer Asked by Michael on December 15, 2020
Q: I am thinking of buying Intel for my grandchildren's account. Do you see any potential for growth in the near future? Please provide recommendations that you see have a good entry price at this time. As well would this be a good time to buy US funds? Thank you.
Stella
Read Answer Asked by Stella on December 14, 2020
Q: Hi 5iR,
Cannabis advertising platform Weedmaps going public with $1.5 billion valuation with blank-check acquisition firm Silver Spike Acquisition Corp. I do realize that SPAC merger companies are usually future growth potential companies. What interests me here is a company that is claiming to be profitable since every year in its operation,
has grown revenue at a CAGR of 40% over the last five years and is on track to deliver $160 million in revenue and $35 million in EBITDA for 2020.
https://mjbizdaily.com/cannabis-advertising-platform-weedmaps-going-public-with-1-5-billion-valuation/.
Can you give your guidance on this. Thanks in advance.
Read Answer Asked by Vinod on December 14, 2020
Q: Hi guys, I have 80 WORK stocks and 25 CRM stocks and was wondering if I should sell my WORK stocks or keep them. With the Slack acquisition from Salesforce, I am not sure what the implications are. Can you please explain and what is beneficial in either keeping or selling my WORK shares. Thank you so much for your service. Keep up the good work! No pun intended.
Dan
Read Answer Asked by Daniel on December 14, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!